May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Electrotransfer Of Plasmids In The Ciliary Muscle: Principle And Potential Therapeutic Application
Author Affiliations & Notes
  • F.F. Behar–Cohen
    INSERM, Paris, France
    U598,
    Rothschild Ophthalmic Foundation, Paris, France
  • C. Bloquel
    INSERM, Paris, France
    U640,
  • R.A. Bejjani
    INSERM, Paris, France
    U598,
  • P. Biggey
    INSERM, Paris, France
    U640,
  • F. Bedioui
    INSERM, Paris, France
    U640,
  • M. Doat
    INSERM, Paris, France
    U598,
  • D. BenEzra
    Ophthalmology, Hadassah Hebrew University Hospital, Jerusalem, Israel
    INSERM, U598, France
  • D. Scherman
    INSERM, Paris, France
    U640,
  • Footnotes
    Commercial Relationships  F.F. Behar–Cohen, None; C. Bloquel, None; R.A. Bejjani, None; P. Biggey, None; F. Bedioui, None; M. Doat, None; D. BenEzra, None; D. Scherman, None.
  • Footnotes
    Support  LSHG–CT–2005–512036, Fondation Avenir
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5107. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F.F. Behar–Cohen, C. Bloquel, R.A. Bejjani, P. Biggey, F. Bedioui, M. Doat, D. BenEzra, D. Scherman; Electrotransfer Of Plasmids In The Ciliary Muscle: Principle And Potential Therapeutic Application . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5107.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Our purpose was to develop a non damaging electrically mediated plasmid delivery technique (electrotransfer) targeted to the ciliary muscle, which can be used as a reservoir tissue for the long–lasting expression and secretion of therapeutic proteins. We then assess the potentiality of this technology in an experimental uveitis model.

Methods: : We designed electrodes and validate electrical conditions suitable for electrotransfer of the ciliary muscle. Localization of the transgene expression was evaluted thanks to GFP reporter gene expression, and kinetic of the expression in the ciliary muscle was evaluated by in vitro measurement of luminescence in ciliary muscle electrotransfered with a luciferase encoding plasmid. Clinical, histological, and TUNEL analysis were performed to ensure the safety of the procedure. EIU was induced in Lewis rats by a single footpad injection of 150 µg Salmonella Typhimurium lipopolysaccharide (LPS). Rats were treated by electrotransfer in the ciliary muscle of a plasmid encoding a chimeric TNF–alpha soluble receptor linked to the Fc fragment of IgG1 (TNFR–Is/IgG1). A single treatment was administred 6 days before the induction of the disease. Twenty–for hours after the disease induction, clinical and histological analyses were performed. Local and systemic TNF–alpha and TNFR–Is rates were also evaluated at this time point.

Results: : High and long–lasting reporter gene expression was observed, which was restricted to the ciliary muscle. TNFR–Is electrotransfer led to elevated protein secretion in aqueous humor and to drastic inhibition of clinical and histological inflammation scores in rats with endotoxin–induced uveitis. No TNFR–Is was detected in the serum, demonstrating the local delivery of proteins using this method. Plasmid electrotransfer to the ciliary muscle, as performed in this study, did not induce any ocular pathology or structural damage.

Conclusions: : Local and sustained therapeutic protein production through ciliary muscle electrotransfer is a promising alternative to repeated intraocular protein administration for a large number of inflammatory, degenerative, or angiogenic diseases.

Keywords: gene transfer/gene therapy • immunomodulation/immunoregulation • uveitis-clinical/animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×